A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma

Non-infectious Anterior Uveitis Clinical Trial

Official title:
A Phase 3 Randomized, Active-Controlled, Double-Masked Study to Evaluate the Safety and Efficacy of TRS01 Eye Drops in the Treatment of Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate the efficacy and safety of TRS01 eye drops compared to active comparator in subjects with active non-infectious anterior uveitis with or without uveitic glaucoma

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05042609
Study type	Interventional
Source	Tarsier Pharma
Contact
Status	Completed
Phase	Phase 3
Start date	September 20, 2021
Completion date	June 29, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02309385` - Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis	Phase 1/Phase 2
Completed	`NCT02406209` - A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis	Phase 2
Not yet recruiting	`NCT04426734` - Evaluation of DEXTENZA in the Management of Pain and Inflammation in Patients With Anterior Uveitis Compared to Standard of Care Topical Corticosteroids	Phase 4
Completed	`NCT04222712` - A Study to Evaluate TRS01 Eye Drops in Participants With Active Non-infectious Anterior Uveitis	Phase 1/Phase 2
Completed	`NCT03131154` - SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.	Phase 3